Protein Synthesis Inhibition by Cycloheximide Does Not Affect the Acute Release of Tissue-Type Plasminogen Activator

Summary

The acute release of tissue-type plasminogen activator (t-PA) was studied in perfused rat hindlegs. Pretreatment of rats with the protein synthesis inhibitor cycloheximide (2 mg/kg) at 1, 3 or 5 h prior to perfusion of rat hindlegs did not influence the amount of t-PA released by platelet-activating factor (20 nM) or bradykinin (1 μM). The amount of t-PA activity that could be extracted from hindleg skeletal muscle was not decreased by cycloheximide pretreatment though it was decreased in lung extracts. The in vivo release of t-PA was not affected by cycloheximide pre treatment. The data suggest that the acute release of t-PA from vascular endothelial cells does not require ongoing protein synthesis, but that acutely released t-PA is derived from a stable endothelial storage pool.

Keywords

Tissue-type plasminogen activator - Release - Rat - Protein synthesis inhibition - Cycloheximide

• References

• 1 Todd AS. Endothelium and fibrinolysis. Bibl Anat 1973; 12: 98-105
• 2 Rijken DC, Wijngaards G, Welbergen J. Relationship between uterine tissue plasminogen activator and the activators in blood and vascular wall. Thromb Res 1980; 18: 815-830
• 3 Knstensen P, Larsson L-I, Nielsen LS, Grondahl-Hansen J, Andreasen PA, Danø K. Human endothelial cells contain one type of plasminogen activator. FEBS Lett 1984; 168: 33-37
• 4 Prowse CV, Cash JD. Physiologic and pharmacologic enhancement of fibrinolysis. Semin Thromb Haemostas 1984; 10: 51-60
• 5 Emeis JJ. The role of lipid mediators in blood fibrinolysis. In: Lipid Mediators in the Immunology of Shock. Paubert-Braquet M. (ed) Plenum Press; New York: 1987. pp 241-248
• 6 Emeis JJ. Mechanisms involved in short-term changes in blood levels of tissue-type plasminogen activator. In: Tissue-type Plasminogen Activator, Physiological and Clinical Aspects. Kluft C. (ed) CRC Press; Boca Raton: 1988. 2 21-35
• 7 Emeis JJ. Perfused rat hindlegs. A model to study plasminogen activator release Thromb Res 1983; 30: 195-203
• 8 Emeis JJ, Kluft C. PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. Blood 1985; 66: 86-91
• 9 Tranquille N, Emeis JJ. Release of tissue-type plasminogen activator is induced in rats by leukotrienes C4 and D4, but not by prostaglandins El, E2 and 12. Br J Pharmacol 1988; 93: 156-164
• 10 Farber JL, Farmar R. Differential effects of cycloheximide on protein and RNA synthesis as a function of dose. Biochem Biophys Res Commun 1973; 51: 626-630
• 11 Rothblum LI, Devlin TM, Ch’ih JJ. Regulation of mammalian protein synthesis in vivo. Biochem J 1976; 156: 151-157
• 12 Verheijen JH, Mullaart E, Chang GT G, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266-269
• 13 Kluft C, Van Wezel AL, Van der Velden CA M, Emeis JJ, Verheijen JH, Wijngaards G. Large-scale production of extrinsic (tissue-type) plasminogen activator from human melanoma cells. In: Advances in Biotechnological Processes. Mizrahi A, Van Wezel AL. (eds) Alan R. Liss; New York: 1983. 2 97-110
• 14 Gaffney PJ, Curtis AD. A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA). Thromb Haemostas 1985; 53: 134-136
• 15 Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-685
• 16 Granelli-Pipemo A, Reich E. A study of proteases and protease- inhibitor complexes in biological fluid. J Exp Med 1978; 148: 223-234
• 17 Kooistra T, Van den Berg J, Töns A, Platenburg G, Rijken DC, Van den Berg E. Butyrate stimulates tissue-type plasminogen activator synthesis in cultured human endothelial blood. Biochem J 1987; 247: 605-612
• 18 Camiolo SM, Siuta MR, Madeja JM. Improved medium for extraction of plasminogen activator from tissue. Prep Biochem 1982; 12: 297-305
• 19 Lowry OH, Rosebrough NL, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275
• 20 Verheijen JH, Chang GT G, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
• 21 Kluft C, Wijngaards G, Van Voorthuizen H. Revised reference curve for the α₂-antiplasmin assay by the addition of detergents. Thromb Haemostas 1984; 51: 297
• 22 Vassalli J-D, Belin D. Amiloride selectively inhibits the urokinase- type plasminogen activator. FEBS Lett 1987; 214: 187-191
• 23 Kelly RB. Pathways of protein secretion in eukaryotes. Science 1985; 230: 25-32
• 24 Bienkowski RS. Intracellular degradation of newly synthesized secretory proteins. Biochem J 1983; 214: 1-10
• 25 Kayar SR, Banchero N. Sequential perfusion of skeletal muscle capillaries. Microvasc Res 1985; 30: 298-305
• 26 Oude Vrielink HH E, Slaaf DW, Tangelder GJ, Reneman RS. Does capillary recruitment exist in young rabbit skeletal muscle. Int J Microcirc Clin Exp 1987; 6: 321-332
• 27 Booyse FM, Bruce R, Dolenar D, Grover M, Casey LC. Rapid release and deactivation of plasminogen activators in human endothelial cell cultures in the presence of thrombin and ionophore A23187. Semin Thromb Haemostas 1986; 12: 228-230
• 28 Kooistra T, Emeis JJ. Histamine and thrombin induce acute release and an increase in constitutive synthesis of t-PA in human endothelial cells in culture. Fibrinolysis 1988; 2 supplement (Suppl. 01) 41 (Abstr)
• 29 Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in Circulation Research. Circ Res 1980; 47: 1-9